Transparency Market Research

Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Posted on Updated on

Drug Device Combination Products MarketThis report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/drug-device-combination.html

Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report.

Some of the major players profiled in this report are Boston Scientific Corporation, Abbott Laboratories, Allergan, Inc., Bayer Healthcare, Medtronic Inc., Bausch and Lomb, Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Browse full PDF with TOC: Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers for the global drug device combination products market. Government and NGO initiatives to promote drug delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug delivery technologies will serve as future growth opportunities for various drug device combination products. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the regulated products and thus complicating their approval process.

Geographically, North America dominated the global drug device combination products market and is expected to continue to lead in terms of revenue generation throughout the forecast period. The market in North American region was valued at USD 28.5 billion in the year 2012.Asia-Pacific is considered as the most lucrative market for drug device combination products owing to the increase in incidences of cardiovascular diseases, diabetes related disorders and obesity through 2019. The leading players in the market for drug device combination products are Abbott Laboratories, Inc., Medtronic, Inc., Boston Scientific Corporation, CareFusion Corporation, Allergen, Inc. and others.
Browse more market research reports: Transparency Market Research

Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019

Posted on Updated on

Nanomedicine MarketTransparency Market Research is Published new Market Report  Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019,” .The market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/nanomedicine-market.html

The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.

The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.

download-pdf

However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.

Browse full report with TOC: Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019

North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.

Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.

The global nanomedicine market is categorized into the following segments:

Nanomedicine Market by Application

  • Neurology
  • Cardiovascular
  • Anti-Inflammatory
  • Anti-Infectives
  • Oncology
  • Others

Nanomedicine Market by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

New Released Report: Global Breast Pumps Market Is Expected to Reach USD 1.03 Billion in 2018: Transparency Market Research

Posted on

According to a new market report published by Transparency Market Research “Breast Pumps Market (Manual, Battery-powered and Electric Pumps) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018” in 2011, the global breast pumps market was valued at USD 0.62 billion and is expected to grow at a CAGR of 7.5% from 2012 to 2018, to reach an estimated value of USD 1.03 billion in 2018.

Browse the full report with TOC: http://www.transparencymarketresearch.com/breast-pumps-market.html

The growth of this market is driven by the rising birth rates globally and the rapidly growing world population. With changing lifestyles and an increase in the number of working women, the consumer base for breast pumps is expanding and so is the demand for these devices. Restructuring of the reimbursement policies, which requires insurance companies to cover the cost of breastfeeding devices and lactation counseling, will also help improve the uptake  of breast pumps. Increasing disposable incomes are strengthening the purchasing power of consumers and rising awareness about the benefits of breastfeeding will further help fuel market growth during the forecast period 2012 to 2018.

Electric pumps market is the fastest growing market segment with a CAGR of 11.9%. The preference for personal use electric pumps is expected to be the highest. In addition, the battery-powered pumps segment was the largest market segment in 2011 and will continue to be the leading segment till 2018, in terms of revenue.

Browse full PDF with TOC: Breast Pumps Market (Manual, Battery-powered and Electric Pumps) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

Geographically, the North American region accounted for the largest market share in 2011. This is mainly due to the large consumer population, availability of advanced medical technologies, strong presence of leading market players and high purchasing power of consumers. However, with a high double digit CAGR of 17.1%, Asia will emerge as the fastest growing market due to the rapidly growing population, increasing awareness, rising disposable incomes and growing economies.

The global breast pumps market is highly consolidated and dominated by players such as Medela, Inc., Philips AVENT and Ameda Breastfeeding Solutions. Of these, Medela, Inc. accounted for the largest market share in 2011. Other small players in this market include Bailey Medical, Energizer Personal Care, LLC (Playtex Baby), Hygeia Medical Group, Lansinoh Laboratories, Inc. and Whittlestone, Inc.

The global breast pumps market is segmented as follows:

Breast Pumps Market, by Pumping System Type

  • Manual
  • Battery-powered
  • Electric
  • Personal Use
  • Hospital Grade

Breast Pumps Market, by Product Design

  • Open System Pumps
  • Closed System Pumps

Biopsy Devices Market, by Geography

  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)

Related Reports:
Endometriosis Market: http://www.transparencymarketresearch.com/endometriosis-market.html
Medical Tourism Market: http://www.transparencymarketresearch.com/medical-tourism.html
X-Ray Market: http://www.transparencymarketresearch.com/x-ray-market.html

Transparency Market Research: Cell Surface Markers Analysis Market is Expected to Reach USD 23.03 Billion Globally in 2019

Posted on

global-cell-surface-markers-market-revenues-by-instruments-and-reagents-2012Transparency Market Research published new market report “Cell Surface Markers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019″ the global cell surface markers market was valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.

Browse the full report: http://www.transparencymarketresearch.com/cell-surface-markers-market.html

Cell surface markers are expressed on the surface of cells and function as identifiers of certain type of cells. The presence of cell markers also assists in the determination of cell type expression of specific receptors vital for biological response. Cell surface marker analysis is also essential in determination of experimental drug or ligand response. Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.

On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Increased market consolidation, simplification of analysis products, cost containment of such products and introduction of cheaper products in less developed markets are the major market strategies which are being adopted by the existing and emerging market players to sustain the cell surface markers market.

Browse full PDF with TOC: Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents and Kits) Market

The global cell surface markers market can be categorized into instruments and reagents, kits and controls used for cell marker analysis. Flow cytometers and hematology analyzers are the prime cell marker analysis equipment used. Flow cytometry is the most prominently used tool for cell marker analysis. Availability of a wide range of flow cytometers and their efficacy in both research and drug discovery are the major factors driving the demand for flow cytometers. It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.

Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis. Cell markers analysis is essential in drug discovery and its use in R&D by pharmaceutical manufacturers and researchers widespread. Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.

Geographically, North America is the dominant regional market for cell surface markers with almost half of the market share. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2019. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.

The cell surface markers market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Some of the major companies in the cell surface markers market include Abbott Laboratories, Beckman Coulter, BD Biosciences, Bio-Rad, Seimens Healthcare, Nihon Kohden Corporation, Sysmex Corporation and Roche Diagnostics.

The global cell surface markers market is segmented as follows:

Cell Surface Markers Market, by Instruments and Reagents

  • Flow Cytometers
  • Hematology Analyzers
  • Reagents and Kits

Cell Surface Markers Market, by Applications

  • Disease Diagnosis and Identification
  • Research and Drug Discovery

Cell Surface Markers Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related Reports:

X-Ray Market: http://www.transparencymarketresearch.com/x-ray-market.html
Medical Tourism Market: http://www.transparencymarketresearch.com/medical-tourism.html

Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

Posted on

medical-educationAccording to the latest market report published by Transparency Market Research “General Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018”, the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report: http://www.transparencymarketresearch.com/general-medicine-education-publishing.html

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

Browse full PDF with TOC: Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson’s Principles and Practice of medicine. A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:

Electronic & online publishing market for general medicine education

  • Online Reference Tools
  • Mobile Applications
  • Electronic & Digital textbooks and reference books
  • Multimedia Content
  • Testing & Self-Assessmen
  • Hospital Training
  • Distance Learning

Print publishing market for general medicine education

  • Custom content publishing
  • Print textbooks and reference books
  • Testing & Self-Assessment
  • Hospital Training
  • Distance Learning

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

  • North America
  • EuropeAsia
  • Rest of the World (RoW)

Related & Recently Published Reports by Transparency Market Research:
CINV Market: http://www.transparencymarketresearch.com/cinv-market.html
High Potency Active Pharmaceutical Ingredients Market: http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

Global Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research

Posted on Updated on

According to a new market report published by Transparency Market Research “Medical Imaging Equipment Market (X-ray, Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Nuclear Imaging Equipment) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019″ in 2012, the global medical imaging equipment market was valued at USD 24.39 billion and is expected to grow at a CAGR of 5.4% during the forecast period of 2013 to 2019  to reach a market value of USD 35.35 billion by 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/medical-imaging-equipment-market.html

Medical imaging equipment helps in diagnosing various complex diseases such as chromosomal abnormalities, atherosclerosis and Parkinson’s disease. This equipment utilizes energy waves to produce 2-D and 3-D images of human organs. With rise in incidences of various diseases such as cardiovascular diseases (CVD), brain disorders, oral conditions such as gingivitis, and lung disorders, the market is expected to grow at a CAGR of 5.4% during the forecast period of 2013 to 2019.

According to an estimate of the World Health Organization (WHO), around 8.7 million people suffered from tuberculosis (TB) in 2011 worldwide and around 23.3 million people will die due to CVDs. Growth of this market will also be supported by the increasing geriatric population worldwide because elderly people are highly susceptible to various diseases such as osteoporosis, stroke and CVDs. Equipment such as nuclear imaging devices and computed tomography (CT) scanners help in diagnosing these diseases precisely within a short span of time. Moreover, introduction of various technologically advanced products such as handheld X-ray machines and upright MRI scanners will also augment growth of this market. This is attributed mainly to increase in their utilization in various medical institutes, such as hospitals and diagnostic labs, since they reduce installation cost and also provide convenience of use.

Likewise, support from various private and government bodies will also trigger the growth of this market. For instance, the U.S. government introduced the Medicare Benefit Schedule (MBS) in 2011 which provides rebates for different categories of items including medical devices. However, imposition of excise tax on the sale of medical devices by the manufacturers and low adoption rate in patients for conventional MRI and CT scanners will hamper the growth of this market. According to the Patient Protection and Affordable Care Act (PPACA) of the U.S., medical device manufacturers are expected to pay an additional medical device excise tax (MDET) of 2.3% on the sale of every device.

Browse full PDF with TOC: Medical Imaging Equipment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The CT scanners and nuclear imaging equipment market segments are expected to show the highest growth among all market segments due to their capability to diagnose large number of diseases effectively in less time. The market for CT scanners was valued at USD 4.35 billion and that for nuclear imaging equipment was value at USD 1.47 billion, in 2012. Both these market segments are expected to show growth at a CAGR of over 5% each.

Geographically, the North American region constituted the largest share by revenue for medical imaging equipment in the year 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of over 7% from 2013 to 2019. This is attributed to rise in geriatric population, and improving healthcare infrastructure in the Asia-Pacific region. In addition, the favorable demand-supply gap for diagnostic services in this region will also propel the growth of this market.

The global medical imaging equipment market is dominated by players such as GE Healthcare, Toshiba America Medical System, Philips Healthcare, Shimadzu Corporation., Siemens Healthcare and Hitachi Medical Corporation. The market is highly oligopolistic in nature with the top three players accounting for about 50% of the global market revenue.

The global medical imaging equipment market has been segmented as below:

Medical Imaging Equipment Market, by Product Types

  • X-ray Devices
    • Stationary X-ray Devices
      • Mobile
      • Handheld
  • Portable X-ray Devices
  • Computed Tomography (CT) Scanners
    • Stationary CT
    • Portable/Mobile CT
  • Ultrasound Systems
    • Trolley/Cart based ultrasound
    • Compact/Portable ultrasound
  • Magnetic Resonance Imaging (MRI) Equipment
    • Closed MRI
    • Open MRI
  • Nuclear Imaging Equipment
    • Single Photon Emission Computed Tomography (SPECT) Scanners
    • Positron Emission Tomography (PET) Scanners

Medical Imaging Equipment Market, by Technology

  • X-ray Devices
    • Analog
    • Computed radiography (CR)
    • Digital radiography (DR)
  • Computed Tomography (CT) Scanners
    • Low-slice scanners
    • Medium-slice scanners
    • High-slice scanners
  • Ultrasound Systems
    • 2-D Imaging
    • 3-D & 4-D Imaging
    • Doppler
    • HIFU
    • Lithotripsy
  • Magnetic Resonance Imaging (MRI) Equipment
    • High-field
    • Medium-field
    • Low-field
  • Nuclear Imaging Equipment
    • Single Photon Emission Computed Tomography (SPECT)
    • Positron Emission Tomography (PET)

Medical Imaging Equipment Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related & Recently Published Reports by Transparency Market Research